Search

Your search keyword '"Dudar I"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Dudar I" Remove constraint Author: "Dudar I"
103 results on '"Dudar I"'

Search Results

1. Pruritus and the Quality of Life in Patients with Chronic Kidney Disease Stage VD Treated by Hemodialysis

2. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

3. Microstructural and transport properties of superconducting FeTe0.65Se0.35 crystals

4. Anisotropy of the magnetic properties of the FeTe0.65Se0.35 superconductor

5. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

8. One year of the full-scale war in Ukraine and kidney replacement therapy: Where do we stand now? A brief report of the Ukrainian Renal Disaster Relief Committee of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists

9. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

10. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

16. Recommendations of the Ukrainian Renal Disaster Relief Committee of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists regarding medical care to kidney disease patients during the war

18. Management of chronic kidney disease patients during the COVID-19 pandemic: Adapted clinical guidelines of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists

19. Management of hemodialysis facilities and services during the COVID-19 pandemic: Adapted clinical guidelines of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists

29. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

34. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

35. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

36. Prospective multicenter study of HX575 (biosimilar epoetin-alpha) in patients with chronic kidney disease applying a target hemoglobin of 10 – 12 g/dl

45. The Effect of Tillage Method on the Nutrient Regime of Soil during the Growing of Trifolium pratense

46. Relationship of potato yield and factors of influence on the background of herbological protection

Catalog

Books, media, physical & digital resources